Skip to main content
. 2005 Jul 21;55(4):451–458. doi: 10.1007/s00262-005-0018-5

Table 3.

HLA-tetramer analyses of tumor-infiltrating lymphocytes (TIL)

Patient TAA-specific TIL TIL as a percentage of live cells in melanoma tissue TAA-specific TIL as a percentage of all TIL in melanoma tissue
1 gp100280–288 10.7 1.5
2 MART26–35 10.2 6.6
3 Tyrosinase368–376 19.0 0.2
4 MART26–35 + gp100154–162 13.9 1.7, 0.8
5 MART26–35 + gp100154–162 18.7 0.3, 4.1
6 gp100154–162 13.3 3.5
7 All negative 7.5 –
8 All negative 5.4 –
18 MART26–35 + gp100154–162 + gp100280–288 14.2 1.4, 2.8, 3.7
19 MART26–35 21.6 4.2
20 MART26–35 9.9 0.9
21 gp100154–162 + gp100280–288 16.5 0.8, 0.9
22 gp100280–288 8.2 1.6
23 gp100280–288 11.6 1.7
24 All negative 7.8 –
25 All negative 27.9 –

The third column shows the percentage of TIL compared to the total number of cells present inside the melanoma tissue and the fourth column shows the percentage of tumor-associated antigen-specific TIL (TAA-specific TIL) compared to the total number of TIL